University College London: Albumin Provides No Benefit to Hospitalised Patients With Advanced Liver Disease
March 05, 2021
March 05, 2021
LONDON, England, March 5 (TNSJou) -- The University College London issued the following news:
Daily infusions of albumin provide no significant health benefit to patients hospitalised with advanced liver cirrhosis, over and above 'standard care', finds a large-scale multicentre trial led by UCL researchers.
Albumin is a protein made in the liver that prevents fluid leaking from the bloodstream to other body tissues and carries various substances throughout the . . .
Daily infusions of albumin provide no significant health benefit to patients hospitalised with advanced liver cirrhosis, over and above 'standard care', finds a large-scale multicentre trial led by UCL researchers.
Albumin is a protein made in the liver that prevents fluid leaking from the bloodstream to other body tissues and carries various substances throughout the . . .